TrialOrphanet journal of rare diseases2018

Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trial.

Raphael Schiffmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.